NIH

U.S. investments in medical and health research and development (R&D) grew by 13.3% over a three year period (2013 – 2015), according to Research!America’s new investment report . However, medical and health R&D represents a small fraction of total spending on health. Currently, the U.S. spends less than 5 cents of every health dollar on R&D to prevent, treat, and cure disease. More than half of Americans (56%) say that is not enough, a recent public opinion survey shows. Industry, including pharmaceutical, medical technolo­gy, biotechnology and health IT companies, invests more in R&D than other sectors. In 2015, industry invested 64.7% of total spending, followed by the...
Founded in 1977, the American Pain Society (APS) is a multidisciplinary organization of basic and clinical scientists, practicing clinicians, policy analysts and others who conduct pain research, treat pain and advocate for individuals with pain. The mission of APS is to advance pain-related research, education, treatment and professional practice. In 2010, after a decade of APS advocacy efforts to address pain as a national issue, the National Institutes of Health (NIH) contracted with the Institute of Medicine (IOM) to undertake a study and make recommendations “to increase the recognition of pain as a significant public health problem in the United States.” According to their landmark...
The American Association for Cancer Research (AACR) has released the annual Cancer Progress Report , highlighting advances in cancer research, as well as advocating for sustained and robust funding for federal health agencies. AACR also hosted a congressional briefing on the progress report on Wednesday, September 21 to bring to Congress’ attention the importance of funding for research and emphasized patient involvement in moving research forward. Patient participation in clinical trials is important not only to test the efficacy of cancer drugs, but also to further the precision medicine initiative that aims to individualize cancer treatment based on each patient’s genetic code and...
Across the United States, hundreds of thousands of researchers are working to better understand a wide range of diseases and conditions, from cancer to heart disease, to rare disorders to Alzheimer disease, and countless others, in order to improve the health and well-being of people in every corner of America and the world. The lifeblood for the majority of these researchers is federal funding received through the National Institutes of Health (NIH). Through more than 57,000 research and training grants, NIH directly supports approximately 300,000 researchers at more than 2,500 universities and organizations located in all 50 states. This funding, in turn, supports local economies and...
Watch the videos from each panel, read the transcript , view the photo gallery and read the WebMD live recap . “The biomedical research enterprise underpins the health of the nation and much of the world, and is in dire need of substantial infusion to meet the great medical needs of our time,” said William N. Hait, M.D., Ph.D. , global head, Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, the keynote speaker at the 2016 National Health Research Forum, added that we’re losing time in addressing threats like the Zika virus, Ebola and cancer while waiting for funding to improve for biomedical research. The program, held Thursday,...
Dear Research Advocate: News this week from researchers in Brazil on hearing loss in infants born to mothers who have been infected with the Zika virus underscores the reality that we are far from seeing light at the end of this public health crisis tunnel. CDC Director Tom Frieden and NIAID Director Tony Fauci wrote on the perils of “robbing Peter to pay Paul” in funding the nation’s response to Zika in yesterday’s Washington Post . We are fortunate to be welcoming both of these leaders to our National Health Research Forum next week, so will have an in-the-moment update. Some 76% of Americans now say Congress should make passing the emergency Zika response an important priority when they...
This blog post originally appeared August 3, 2016 on the Sick Chicks and The Mighty . "Congress is working together on a nonpartisan issue that will have a profound effect on the lives of all Americans. H.R. 6, the 21st Century Cures Act, will bring our health care innovation infrastructure into the 21st Century, delivering hope for patients and loved ones and providing necessary resources to researchers to continue their efforts to uncover the next generation of cures and treatments." - Mission Statement , House Committee of Energy Commerce, 21st Century Cures Is it just me or do you get chills reading that paragraph? Finding advocacy allowed me take control of an uncontrollable situation...
Dear Research Advocate: Both the Republican and Democratic platforms highlight the importance of achieving medical progress, responding to the fact that Americans place a high value on achieving health and wellness (see my Huffington Post blog last Friday discussing our newest survey results ). A portion of the first day of the Democratic convention this week was devoted to public health topics, including the opioid abuse crisis . Secretary Clinton chose Senator Tim Kaine as her running mate, a policymaker with a solid track record on public health; a strong proponent of prevention. In Sen. Kaine’s speech last evening, he emphasized the importance of research to defeat Alzheimer’s and...
Dear Research Advocate: The party conventions mark the official start to the general election. In Cleveland we heard rousing daily themes of “Make America (aspirational word) Again”. I kept hoping for “healthy” or “innovative,” aspirations we know rank high with Americans, but that was not to be. Nor -- at least as of this writing -- have any speakers addressed medical progress. Even so, the official Republican platform recognizes the importance of medical research and innovation for our economy and for patients. The Democratic platform , which will be adopted at the DNC convention next week, in fact makes similar points. We’ll see if research and innovation make it into the convention...
Dear Research Advocate: Today, the House Labor-HHS appropriations subcommittee marked up its FY17 funding bill, which includes funding for NIH, CDC and AHRQ. NIH received a $1.25 billion increase, $750 million less than the Senate increase. Given the subcommittee’s overall budget allocation ($569 million below fiscal year 2016) and the more conservative funding climate in the House, this is still an extraordinarily positive outcome. At the markup, Chairman Tom Cole (R-OK-04) noted that the $1.25 billion increase set a floor - rather than a ceiling - for NIH funding in FY17, a positive sign for potential negotiations with the Senate later in the process. The House Labor-HHS bill proposes a...

Pages

Sidebar Quote

Public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.
Abraham Lincoln